936446-61-6 (NRC-2694,NRC-2694)

NRC-2694;NRC2694;N-(3-Ethynylphenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;(3-Ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine;NRC 2694;BDBM50455959;G15936;AKOS040742312;EGFR Inhibitor NRC-2694;CS-6754;N-(3-Ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;N-(3-ethynylphenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine;UNII-O898S9836V;936446-61-6;SCHEMBL828788;HY-19909;BCP30237;DB-209593;4-Quinazolinamine, N-(3-ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-;N-(3-Ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine;CHEMBL5281903;NRC-2694?;WBKHQQZRHCECKK-UHFFFAOYSA-N;AC-36681;O898S9836V;N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;MS-27321;Q27285472;NRC 2694; NRC2694;

WBKHQQZRHCECKK-UHFFFAOYSA-N

1S/C24H26N4O3/c1-3-18-6-4-7-19(14-18)27-24-20-15-23(22(29-2)16-21(20)25-17-26-24)31-11-5-8-28-9-12-30-13-10-28/h1,4,6-7,14-17H,5,8-13H2,2H3,(H,25,26,27)

C1(NC2=NC=NC3C=C(OC)C(OCCCN4CCOCC4)=CC=32)=CC(C#C)=CC=C1